COONasdaqOphthalmic GoodsFiscal year ends October 31
COOPER COMPANIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$58.16+0.22 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $11.25B
- P/E (TTM)
- 19.8
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
210M of 190M shares
Institutional holders
670
112 new, 101 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
10 buys · 0 sales
Net bought $3.18M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vanguard Capital Management | 14,664,697 | 7.51% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 14,137,034 | 7.10% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of COO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 15,029,453 | 7.90% | $1.08B | −1,588,676 | 0.02% |
| Vanguard Capital Management LLC | 12,758,769 | 6.71% | $914.93M | +39,940 | 0.02% |
| State Street Corp | 8,892,643 | 4.68% | $637.69M | +124,224 | 0.02% |
| Vanguard Portfolio Management LLC | 8,669,690 | 4.56% | $621.70M | −51,641 | 0.03% |
| T. Rowe Price Investment Management, Inc. | 7,429,535 | 3.91% | $532.77K | −1,630,642 | 0.35% |
| Browning West LP | 7,195,428 | 3.78% | $515.98M | +215,899 | 30.53% |
| Price T Rowe Associates Inc /Md/ | 5,579,650 | 2.93% | $400.12K | +185,770 | 0.04% |
| Kayne Anderson Rudnick Investment Management LLC | 5,430,282 | 2.86% | $389.41M | −1,186,395 | 1.21% |
| Geode Capital Management, LLC | 5,359,812 | 2.82% | $382.87M | +48,289 | 0.02% |
| Franklin Resources Inc | 5,096,888 | 2.68% | $365.50M | +229,606 | 0.08% |
| Generation Investment Management Llp | 4,968,673 | 2.61% | $356.30M | +369,284 | 3.46% |
| Jupiter Topco LLC | 4,254,267 | 2.24% | $305.07M | New | 0.12% |
| Aqr Capital Management LLC | 4,022,614 | 2.12% | $285.69M | +295,427 | 0.10% |
| Arrowstreet Capital, Limited Partnership | 4,004,357 | 2.11% | $287.15M | +1,878,057 | 0.13% |
| Longview Partners (Guernsey) LTD | 3,940,007 | 2.07% | $282.54M | +116,945 | 4.59% |
| UBS Group AG | 3,932,013 | 2.07% | $281.96M | +496,795 | 0.04% |
| Citadel Advisors LLC | 3,872,397 | 2.04% | $277.69M | +3,679,872 | 0.03% |
| Invesco Ltd. | 3,685,038 | 1.94% | $264.25M | +28,227 | 0.02% |
| JANA Partners Management, LP | 3,582,480 | 1.88% | $256.90M | +17,322 | 13.50% |
| Wellington Management Group Llp | 3,468,951 | 1.82% | $248.76M | +103,044 | 0.04% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 670 | 210M | 100.0% | 112 / 257 | 237 / 101 | 34M | 26M |
| Q1 2026 | 673 | 205M | 100.0% | 107 / 239 | 239 / 86 | 45M | 25M |
| Q4 2025 | 663 | 209M | 100.0% | 122 / 220 | 245 / 69 | 39M | 35M |
| Q3 2025 | 625 | 205M | 100.0% | 89 / 210 | 260 / 75 | 32M | 28M |
| Q2 2025 | 619 | 201M | 100.0% | 82 / 240 | 235 / 87 | 29M | 25M |
| Q1 2025 | 631 | 197M | 100.0% | 68 / 229 | 248 / 101 | 20M | 16M |
| Q4 2024 | 670 | 196M | 100.0% | 97 / 236 | 249 / 71 | 17M | 17M |
| Q3 2024 | 651 | 196M | 100.0% | 87 / 231 | 252 / 45 | 30M | 14M |
| Q2 2024 | 616 | 197M | 100.0% | 99 / 258 | 186 / 47 | 18M | 16M |
| Q1 2024 | 570 | 195M | 100.0% | 564 / 4 | 2 / 0 | 194M | 0M |
| Q4 2023 | 6 | 1M | 0.8% | 5 / 0 | 0 / 0 | 1M | 0M |
| Q3 2023 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of COO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 6,190,598 | 3.26% | $443.93M | 0.02% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 5,056,888 | 2.66% | $362.63M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,474,193 | 2.35% | $320.84M | 0.17% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 3,883,712 | 2.04% | $278.50M | 1.21% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 2,834,574 | 1.49% | $203.27M | 0.30% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 2,758,744 | 1.45% | $197.83M | 1.21% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,753,527 | 1.45% | $199.14M | 0.21% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 2,683,305 | 1.41% | $192.42M | 0.02% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund | 2,524,929 | 1.33% | $181.06M | 0.81% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 2,507,944 | 1.32% | $153.51M | 0.02% | May 31, 2026 |
| Touchstone Funds Group Trust-Touchstone Mid Cap Fund | 2,289,100 | 1.20% | $164.15M | 3.64% | Jun 30, 2026 |
| Vanguard Windsor Fund | 2,086,910 | 1.10% | $150.93M | 0.60% | Jul 31, 2026 |
| Franklin Mutual Shares Fund | 1,969,415 | 1.04% | $141.23M | 2.03% | Jun 30, 2026 |
| Franklin Mutual Beacon Fund | 1,602,363 | 0.84% | $114.91M | 3.35% | Jun 30, 2026 |
| Bridge Builder Large Cap Growth Fund | 1,560,645 | 0.82% | $111.91M | 0.37% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Albert G. White III | President & CEO, Director | 254,491 | 0.13% | Feb 13, 2026 |
| Brian G. Andrews | EVP, CFO & Treasurer | 30,728 | 0.02% | Feb 13, 2026 |
| Gerard H. Warner III | President, CooperVision, Inc. | 20,971 | 0.01% | Jan 12, 2026 |
| Holly R. Sheffield | President, CSI | 48,516 | 0.03% | Jan 12, 2026 |
| Daniel G. McBride | EVP & Chief Operating Officer | 165,967 | 0.09% | Jan 12, 2026 |
| Agostino Ricupati | SVP & CAO | 8,020 | 0.00% | Apr 3, 2025 |
| Nicholas Khadder | VP, General Counsel & Corp Sec | 3,790 | 0.00% | Jan 10, 2025 |
| Lawrence Erik Kurzius | Director | 31,099 | 0.02% | Sep 17, 2026 |
| Paul A. Keel | Director | 4,701 | 0.00% | Sep 15, 2026 |
| Walter M. Rosebrough Jr | Director | 20,832 | 0.01% | Sep 15, 2026 |
| Barbara Carbone | Director | 3,050 | 0.00% | Apr 6, 2026 |
| Robert S. Weiss | Director | 550,459 | 0.29% | Apr 6, 2026 |
| Colleen Jay | Director | 39,907 | 0.02% | Apr 6, 2026 |
| Maria Rivas | Director | 14,463 | 0.01% | Apr 6, 2026 |
| Teresa S. Madden | Director | 15,679 | 0.01% | Apr 6, 2026 |
| Cynthia L. Lucchese | Director | 12,767 | 0.01% | Apr 6, 2026 |
| William A. Kozy | Director | 31,149 | 0.02% | Apr 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Lawrence Erik Kurzius Director | Sep 16, 2026 | Buy | +10,000 | $54.93 | $549.30K | 31,099 |
| Walter M. Rosebrough Jr Director | Sep 14, 2026 | Buy | +3,000 | $54.29 | $162.87K | 20,000 |
| Lawrence Erik Kurzius Director | Sep 14, 2026 | Buy | +10,000 | $53.92 | $539.20K | 21,099 |
| Walter M. Rosebrough Jr Director | Sep 11, 2026 | Buy | +7,000 | $54.11 | $378.77K | 17,000 |
| Paul A. Keel Director | Sep 11, 2026 | Buy | +4,701.02 | $53.18 | $250.00K | 4,701 |
| Walter M. Rosebrough Jr Director | Apr 1, 2026 | Option exercise | +832 | – | – | 832 |
| Maria Rivas Director | Apr 1, 2026 | Option exercise | +3,322 | – | – | 3,322 |
| Colleen Jay Director | Apr 1, 2026 | Option exercise | +3,322 | – | – | 39,907 |
| Cynthia L. Lucchese Director | Apr 1, 2026 | Option exercise | +3,322 | – | – | 12,767 |
| Teresa S. Madden Director | Apr 1, 2026 | Option exercise | +3,322 | – | – | 15,679 |
| Barbara Carbone Director | Apr 1, 2026 | Option exercise | +3,050 | – | – | 3,050 |
| Lawrence Erik Kurzius Director | Apr 1, 2026 | Option exercise | +3,322 | – | – | 11,099 |
| Robert S. Weiss Director | Apr 1, 2026 | Option exercise | +3,654 | – | – | 292,599 |
| Colleen Jay Director | Jan 12, 2026 | Option exercise | +7,064 | $39.40 | $278.32K | 36,585 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Option exercise | +3,304 | – | – | 47,102 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Tax withholding | −1,462 | $83.13 | $121.54K | 45,640 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Tax withholding | −738 | $83.13 | $61.35K | 44,902 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Tax withholding | −1,641 | $83.13 | $136.42K | 43,261 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Option exercise | +1,592 | – | – | 43,798 |
| Holly R. Sheffield President, CSI | Jan 8, 2026 | Option exercise | +3,154 | – | – | 42,206 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Tax withholding | −2,121 | $83.13 | $176.32K | 71,471 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Tax withholding | −2,119 | $83.13 | $176.15K | 69,352 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Option exercise | +4,168 | – | – | 67,288 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Option exercise | +4,163 | – | – | 76,007 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Tax withholding | −2,415 | $83.13 | $200.76K | 73,592 |
| Daniel G. McBride EVP & Chief Operating Officer | Jan 8, 2026 | Option exercise | +4,556 | – | – | 71,844 |
| Brian G. Andrews EVP, CFO & Treasurer | Jan 8, 2026 | Tax withholding | −1,893 | $83.13 | $157.37K | 8,537 |
| Brian G. Andrews EVP, CFO & Treasurer | Jan 8, 2026 | Option exercise | +3,528 | – | – | 10,430 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Option exercise | +2,652 | – | – | 20,971 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Tax withholding | −1,354 | $83.13 | $112.56K | 23,852 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Option exercise | +3,154 | – | – | 24,125 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Option exercise | +1,232 | – | – | 25,357 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Option exercise | +2,940 | – | – | 28,297 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Option exercise | +1,540 | – | – | 29,837 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Tax withholding | −1,714 | $83.13 | $142.48K | 28,123 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Tax withholding | −629 | $83.13 | $52.29K | 27,494 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Tax withholding | −787 | $83.13 | $65.42K | 26,707 |
| Gerard H. Warner III President, CooperVision, Inc. | Jan 8, 2026 | Tax withholding | −1,501 | $83.13 | $124.78K | 25,206 |
| Albert G. White III President & CEO, Director | Jan 8, 2026 | Option exercise | +18,340 | – | – | 254,491 |
| Albert G. White III President & CEO, Director | Jan 8, 2026 | Tax withholding | −9,419 | $83.13 | $783.00K | 245,072 |
| Cynthia L. Lucchese Director | Dec 22, 2025 | Buy | +1,784 | $84.06 | $149.96K | 9,445 |
| Maria Rivas Director | Dec 18, 2025 | Buy | +1,000 | $82.13 | $82.13K | 11,141 |
| Lawrence Erik Kurzius Director | Dec 17, 2025 | Buy | +2,000 | $82.50 | $165.00K | 7,777 |
| Albert G. White III President & CEO, Director | Dec 16, 2025 | Buy | +10,000 | $80.80 | $808.00K | 236,151 |
| Holly R. Sheffield President, CSI | Dec 16, 2025 | Buy | +1,230 | $80.75 | $99.32K | 39,052 |
| Robert S. Weiss Director | Dec 12, 2025 | Gift | −7,500 | – | – | 257,860 |
| Lawrence Erik Kurzius Director | Sep 29, 2025 | Buy | +2,000 | $68.39 | $136.78K | 5,777 |
| Gerard H. Warner III President, CooperVision, Inc. | Sep 5, 2025 | Buy | +1,450 | $69.23 | $100.38K | 18,319 |
| Albert G. White III President & CEO, Director | Sep 5, 2025 | Buy | +10,000 | $68.39 | $683.90K | 226,151 |
| Daniel G. McBride EVP & Chief Operating Officer | Sep 2, 2025 | Buy | +3,000 | $65.04 | $195.12K | 63,120 |
| Brian G. Andrews EVP, CFO & Treasurer | Sep 2, 2025 | Buy | +1,525 | $65.68 | $100.16K | 22,191 |
| Colleen Jay Director | Apr 1, 2025 | Option exercise | +2,721 | – | – | 29,521 |
| Cynthia L. Lucchese Director | Apr 1, 2025 | Option exercise | +2,721 | – | – | 7,661 |
| William A. Kozy Director | Apr 1, 2025 | Option exercise | +2,857 | – | – | 31,149 |
| Robert S. Weiss Director | Apr 1, 2025 | Option exercise | +2,993 | – | – | 288,945 |
| Agostino Ricupati SVP & CAO | Apr 1, 2025 | Tax withholding | −1,055 | $81.27 | $85.74K | 8,020 |
| Agostino Ricupati SVP & CAO | Apr 1, 2025 | Option exercise | +2,076 | – | – | 9,044 |
| Lawrence Erik Kurzius Director | Apr 1, 2025 | Option exercise | +2,721 | – | – | 3,777 |
| Teresa S. Madden Director | Apr 1, 2025 | Option exercise | +2,721 | – | – | 12,357 |
| Maria Rivas Director | Apr 1, 2025 | Option exercise | +2,721 | – | – | 2,721 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| G. White Albert III Officer | Sep 19, 2024 | 114,992 | $12.71M | Sep 19, 2024 | stock option release |
| Ricupati Agostino Director | Sep 10, 2024 | 1,601 | $172.95K | Sep 10, 2024 | restricted stock release |
| G. Andrews Brian Officer | Sep 5, 2024 | 24,788 | $2.62M | Sep 5, 2024 | stock option exercise |
| McBride Daniel Officer | Sep 4, 2024 | 114,992 | $12.13M | Sep 4, 2024 | stock option release |
| Gary and Catherine Petersmeyer Trust dated November 9, 1999 Director | Jun 4, 2024 | 300 | $28.24K | Jun 4, 2024 | restricted stock release |
| Gary and Catherine Petersmeyer Trust dated November 9, 1999 Director | Apr 18, 2024 | 1,106 | $99.84K | Apr 18, 2024 | restricted stock release |
| Gary and Catherine Petersmeyer Trust dated November 9, 1999 Director | Apr 9, 2024 | 500 | $49.24K | Apr 9, 2024 | restricted stock release |
| Gary and Catherine Petersmeyer Trust dated November 9, 1999 Director | Apr 4, 2024 | 1,005 | $100.45K | Apr 4, 2024 | restricted stock vesting |
| Ricupati Agostino Officer | Mar 18, 2024 | 54,724 | $5.52M | Mar 18, 2024 | Stock Option Exercise |
| Weiss Robert Director | Mar 7, 2024 | 241,288 | $24.00M | Mar 7, 2024 | stock option exercise |
| Gary and Catherine Petersmeyer Trust The Director | Mar 5, 2024 | 1,000 | $103.56K | Mar 5, 2024 | Restricted Stock Vesting |
| Gary and Catherine Petersmeyer Trust dated November 9, 1999 Director | Jan 4, 2024 | 150 | $54.80K | Jan 4, 2024 | Restricted Stock Release |
| Weiss Robert Director | Dec 19, 2023 | 79,370 | $29.05M | Dec 19, 2023 | stock option exercise |
| Gary and Catherine Petersmeyer Trust dated Nov 9, 1999 Director | Dec 14, 2023 | 300 | $110.57K | Dec 14, 2023 | Restricted Stock Release |